)
)
Pear Therapeutics Investor Relations Material
Latest events
Q3 2022
Pear Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Pear Therapeutics Inc
Access all reports
Pear Therapeutics, Inc. is a commercial-stage healthcare company. The Company develops and sells software-based medicines that are designed to be used with commercially available sensors and electrocardiogram (EKG) devices. Pear Therapeutics’ software-based medicines apply data-driven machine learning, artificial intelligence, and novel intervention design to provide physicians and patients with personalized, evidence-based medical recommendations for atrial fibrillation (AF) treatment. The company's software is available in more than 200 hospitals across the United States.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
PEAR
Country
🇺🇸 United States